Phosphorylation of Histone H2AX and Activation of Mre11, Rad50, and Nbs1 in Response to Replication-dependent DNA Double-strand Breaks Induced by Mammalian DNA Topoisomerase I Cleavage Complexes
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
DNA double-strand breaks originating from diverse causes in eukaryotic cells are accompanied by the formation of phosphorylated H2AX (gammaH2AX) foci. Here we show that gammaH2AX formation is also a cellular response to topoisomerase I cleavage complexes known to induce DNA double-strand breaks during replication. In HCT116 human carcinoma cells exposed to the topoisomerase I inhibitor camptothecin, the resulting gammaH2AX formation can be prevented with the phosphatidylinositol 3-OH kinase-related kinase inhibitor wortmannin; however, in contrast to ionizing radiation, only camptothecin-induced gammaH2AX formation can be prevented with the DNA replication inhibitor aphidicolin and enhanced with the checkpoint abrogator 7-hydroxystaurosporine. This gammaH2AX formation is suppressed in ATR (ataxia telangiectasia and Rad3-related) deficient cells and markedly decreased in DNA-dependent protein kinase-deficient cells but is not abrogated in ataxia telangiectasia cells, indicating that ATR and DNA-dependent protein kinase are the kinases primarily involved in gammaH2AX formation at the sites of replication-mediated DNA double-strand breaks. Mre11- and Nbs1-deficient cells are still able to form gammaH2AX. However, H2AX-/- mouse embryonic fibroblasts exposed to camptothecin fail to form Mre11, Rad50, and Nbs1 foci and are hypersensitive to camptothecin. These results demonstrate a conserved gammaH2AX response for double-strand breaks induced by replication fork collision. gammaH2AX foci are required for recruiting repair and checkpoint protein complexes to the replication break sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Experimental results have indicated that γ-H2AX foci colocalize with DSB repair factors (such as Rad51, BRCA1, Mre11, Rad50, and Nbs1) [86, 91] and participate the repair of DSBs [85, 89, 90].”
From Markers of cellular senescence. Telomere shortening as a marker of cellular senescence (2016) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438
Self-citationMegabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo
Rogakou, E. P., Boon, C., Redon, C., & Bonner, W. M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.905 · Cited by 2,422
Self-citationCellular roles of DNA topoisomerases: a molecular perspective
Wang, J. C. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm831 · Cited by 2,353
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098
Self-citationATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks
Burma, S., Chen, B. P., Murphy, M., Kurimasa, A., & Chen, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100466200 · Cited by 1,954
Genomic Instability in Mice Lacking Histone H2AX
Celeste, A., Petersen, S., Romanienko, P. J., Fernandez-Capetillo, O., Chen, H. T., Sedelnikova, O. A., Reina-San-Martin, B., Coppola, V., Meffre, E., Difilippantonio, M. J., et al. (2002) · Science · doi:10.1126/science.1069398 · Cited by 1,385
Self-citationNoda, K., Nishiwaki, Y., Kawahara, M., Negoro, S., Sugiura, T., Yokoyama, A., Fukuoka, M., Mori, K., Watanabe, K., Tamura, T., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003034 · Cited by 1,371
Chromosomal stability and the DNA double-stranded break connection
van Gent, D. C., Hoeijmakers, J. H. J., & Kanaar, R. (2001) · Nature Reviews Genetics · doi:10.1038/35056049 · Cited by 1,219
Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress
Ward, I. M., & Chen, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100569200 · Cited by 1,150
Hsiang, Y. H., Lihou, M. G., & Liu, L. F. (1989) · PubMed · Cited by 1,028
Research works printed but not linked: 14
- Pourquier, 2001, Cancer Res., 61, 53
- Takimoto, 1997, Oncology (Huntington), 11, 1635
- Garcia-Carbonero, 2002, Clin. Cancer Res., 8, 641
- Holm, 1989, Cancer Res., 49, 6365
- Hsiang, 1989, Cancer Res., 49, 5077
- Snapka, 1986, Mol. Cell. Biol., 6, 4221
- Tsao, 1993, Cancer Res., 53, 5908
- Shao, 1997, Cancer Res., 57, 4029
- Sarkaria, 1998, Cancer Res., 58, 4375
- Powis, 1994, Cancer Res., 54, 2419
- Yu, 2002, Cancer Res., 62, 5743
- Busby, 2000, Cancer Res., 60, 2108
- Guo, 2002, Cell Growth Differ., 13, 77
- Bunch, 1996, Clin. Cancer Res., 2, 791
Cited by
Items 201–300 of 509
Albino, A. P., Jorgensen, E. D., Rainey, P., Gillman, I. G., Clark, T. J., Gietl, D., Zhao, H. L., Traganos, F., & Darżynkiewicz, Z. (2009) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2009.06.009 · Cited by 49
Kiselev, E., Sooryakumar, D., Agama, K., Cushman, M., & Pommier, Y. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401471v · Cited by 48
Self-citationPhosphatase Type 2A-dependent and -independent Pathways for ATR Phosphorylation of Chk1
Li, G., Elder, R. T., Qin, K., Park, H. U., Liang, D., & Zhao, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607951200 · Cited by 48
Histone modifications and DNA double-strand break repair
Moore, J. D., & Krebs, J. E. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-034 · Cited by 48
Histone H2AX is a critical factor for cellular protection against DNA alkylating agents
Meador, J. A., Zhao, M., Su, Y., Narayan, G., Geard, C. R., & Balajee, A. S. (2008) · Oncogene · doi:10.1038/onc.2008.187 · Cited by 47
Meng, L., Kohlhagen, G., Liao, Z., Antony, S., Sausville, E. A., & Pommier, Y. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0003 · Cited by 47
Self-citationSakasai-Sakai, A., Takata, T., Takino, J.-I., & Takeuchi, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14711-3 · Cited by 46
LMTK3 confers chemo-resistance in breast cancer
Stebbing, J., Shah, K., Lit, L. C., Gagliano, T., Ditsiou, A., Wang, T., Wendler, F., Simon, T., Szabó, K. S., O’Hanlon, T., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0197-0 · Cited by 46
Pol η is required for DNA replication during nucleotide deprivation by hydroxyurea
de Feraudy, S. M., Limoli, C. L., Giedzinski, E., Karentz, D., Marti, T. M., Feeney, L., & Cleaver, J. E. (2007) · Oncogene · doi:10.1038/sj.onc.1210385 · Cited by 45
Mirault, M.-É., Boucher, P., & Tremblay, A. (2006) · The American Journal of Human Genetics · doi:10.1086/507791 · Cited by 45
Development of an Automated γ-H2AX Immunocytochemistry Assay
Hou, Y.-N., Lavaf, A., Huang, D., Peters, S., Huq, R., Friedrich, V. L., Rosenstein, B. S., & Kao, J. (2009) · Radiation Research · doi:10.1667/rr1349.1 · Cited by 45
Furuta, T., Hayward, R. L., Meng, L.-H., Takemura, H., Aune, G. J., Bonner, W. M., Aladjem, M. I., Kohn, K. W., & Pommier, Y. G. (2006) · Oncogene · doi:10.1038/sj.onc.1209313 · Cited by 45
Self-citationBaure, J., Izadi, A., Suarez, V., Giedzinski, E., Cleaver, J. E., Fike, J. R., & Limoli, C. L. (2008) · Mutagenesis · doi:10.1093/mutage/gen064 · Cited by 43
Churchman, M. L., Roig, I., Jasin, M., Keeney, S., & Sherr, C. J. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002157 · Cited by 42
Combination of arsenic trioxide and chemotherapy in small cell lung cancer
Zheng, C., Lam, S. K., Li, Y., Fong, B. M.-W., Mak, J., & Ho, J. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.08.022 · Cited by 42
H2AX a Promising Biomarker for Lung Cancer: A Review
Matthaios, D., Hountis, P. G., Karakitsos, P., Bouros, D. E., & Kakolyris, S. (2013) · Cancer Investigation · doi:10.3109/07357907.2013.849721 · Cited by 41
Guirouilh‐Barbat, J., Antony, S., & Pommier, Y. G. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0336 · Cited by 41
Self-citationResveratrol enhances pluripotency of mouse embryonic stem cells by activating AMPK/Ulk1 pathway
Suvorova, I. I., Knyazeva, A. R., Petukhov, A. V., Aksenov, N. D., & Pospelov, V. A. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0137-y · Cited by 41
Camptothecin effectively treats obesity in mice through GDF15 induction
Lu, J. F., Zhu, M., Xie, B., Shi, X., Liu, H., Zhang, R. X., Xia, B., & Wu, J. W. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001517 · Cited by 41
Alkene–Tetrazine Ligation for Imaging Cellular DNA
Rieder, U., & Luedtke, N. W. (2014) · Angewandte Chemie · doi:10.1002/ange.201403580 · Cited by 41
Bernal, J. A., de la Roche, M., Méndez‐Vidal, C., Espina, Á. G., Tortolero, M., & Pintor‐Toro, J. A. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402254 · Cited by 41
Generation of Replication-Dependent Double-Strand Breaks by the Novel N2-G-Alkylator S23906-1
Léonce, S., Kraus‐Berthier, L., Golsteyn, R. M., David‐Cordonnier, M., Tardy, C., Lansiaux, A., Poindessous, V., Larsen, A. K., & Pierré, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3946 · Cited by 40
Andreyeva, E. N., Kolesnikova, T. D., Belyaeva, E. S., Glaser, R. L., & Zhimulev, I. F. (2008) · Chromosome Research · doi:10.1007/s10577-008-1244-4 · Cited by 41
Sooryakumar, D., Dexheimer, T. S., Teicher, B. A., & Pommier, Y. G. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1043 · Cited by 40
Self-citationSynthetic lethality by targeting the RUVBL1/2-TTT complex in mTORC1-hyperactive cancer cells
Shin, S. H., Lee, J. S., Zhang, J., Choi, S., Bošković, Ž., Zhao, R., Song, M., Wang, R., Tian, J., Lee, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay9131 · Cited by 39
Bandyopadhyay, K., & Gjerset, R. A. (2010) · Biochemistry · doi:10.1021/bi101110e · Cited by 39
Kim, S.-Y., Rhee, J. G., Song, X., Prochownik, E. V., Spitz, D. R., & Lee, Y. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050423 · Cited by 39
Yao, K., Wu, W., Yu, Y., Zeng, Q., He, J., Lu, D.-Q., & Wang, K. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1333 · Cited by 39
RetractedImportance of PIKKs in NF-κB activation by genotoxic stress
Sabatel, H., Pirlot, C., Piette, J. G., & Habraken, Y. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.105 · Cited by 40
Yang, H., Luo, J., Liu, Z., Zhou, R., & Luo, H. (2015) · Cancer Investigation · doi:10.3109/07357907.2015.1006329 · Cited by 39
Martin, S. E., Wu, Z., Gehlhaus, K., Jones, T. L., Zhang, Y., Guha, R., Miyamoto, S., Pommier, Y. G., & Caplen, N. J. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911797264734 · Cited by 39
Self-citationClass Switch Recombination: An Emerging Mechanism
Kenter, A. L. (2005) · Springer eBooks · doi:10.1007/3-540-26363-2_8 · Cited by 41
Distinct roles for PARP-1 and PARP-2 in c-Myc–driven B-cell lymphoma in mice
Galindo-Campos, M. A., Lutfi, N., Bonnin, S., Martínez, C. M., Velasco-Hernández, T., García‐Hernández, V., Martín‐Caballero, J., Ampurdanés, C., Gimeno, R., Colomo, L., et al. (2021) · Blood · doi:10.1182/blood.2021012805 · Cited by 39
Tomicic, M. T., Christmann, M., & Kaina, B. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.159962 · Cited by 38
Sakasai, R., Shinohe, K., Ichijima, Y., Okita, N., Shibata, A., Asahina, K., & Teraoka, H. (2006) · Genes to Cells · doi:10.1111/j.1365-2443.2006.00942.x · Cited by 39
BRCA1 Forms a Functional Complex with γ ‐H2AX as a Late Response to Genotoxic Stress
Krum, S. A., Dalugdugan, E. D. L. R., Miranda‐Carboni, G. A., & Lane, T. F. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/801594 · Cited by 38
Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma
Georgescu, M., Islam, M. Z., Li, Y., Circu, M. L., Traylor, J. G., Notarianni, C., Kline, C., & Burns, D. K. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00992-9 · Cited by 37
Srivastava, V. K., Gara, R. K., Bhatt, M. L. B., Sahu, D. P., & Mishra, D. P. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.049 · Cited by 37
Li, T., Wang, J., Wang, X., Yang, N. Y., Chen, S.-M., Tong, L., Yang, C., Meng, L., & Ding, J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167940 · Cited by 37
4-Nitroquinoline-1-Oxide Induces the Formation of Cellular Topoisomerase I-DNA Cleavage Complexes
Miao, Z., Rao, V. A., Agama, K., Antony, S., Kohn, K. W., & Pommier, Y. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4471 · Cited by 37
Self-citationTanaka, T., Kurose, A., Halicka, H. D., Traganos, F., & Darżynkiewicz, Z. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2681 · Cited by 37
Restelli, V., Lupi, M., Chilà, R., Vagni, M., Tarantelli, C., Spriano, F., Gaudio, E., Bertoni, F., Damia, G. L. M., & Carrassa, L. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0919 · Cited by 36
Netterfield, T. S., Ostheimer, G. J., Tentner, A. R., Joughin, B. A., Dakoyannis, A. M., Sharma, C. D., Sorger, P. K., Janes, K. A., Lauffenburger, D. A., & Yaffe, M. B. (2022) · Cell Systems · doi:10.1016/j.cels.2023.06.005 · Cited by 36
Kurosawa, A., Saito, S., So, S., HASHIMOTO, M. W., Iwabuchi, K., Watabe, H., & Adachi, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072253 · Cited by 35
Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma
Ströbel, T., Madlener, S., Tuna, S., Vose, S. C., Lagerweij, T., Würdinger, T., Vierlinger, K., Wöehrer, A., Price, B. D., Demple, B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10013-w · Cited by 34
Meng, L., & Ding, J. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00698.x · Cited by 34
A hypophosphorylated form of RPA34 is a specific component of pre-replication centers
Françon, P., Lemaître, J.-M., Dreyer, C., Maiorano, D., Cuvier, O., & Méchali, M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01361 · Cited by 34
Lansiaux, A., Léonce, S., Kraus‐Berthier, L., Mahieu, C., Mazinghien, R., Didier, S., David‐Cordonnier, M., Hautefaye, P., Lavielle, G., Bailly, C., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.034637 · Cited by 34
Hsu, H.-L., Shi, B., & Gartenhaus, R. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208680 · Cited by 34
Guo, L., Liu, X., Nishikawa, K., & Plunkett, W. K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0780 · Cited by 33
CSA and CSB play a role in the response to DNA breaks
Pascucci, B., Fragale, A., Marabitti, V., Leuzzi, G., Calcagnile, A. S., Parlanti, E., Franchitto, A., Dogliotti, E., & D’Errico, M. (2018) · Oncotarget · doi:10.18632/oncotarget.24342 · Cited by 32
Analysis of Individual Molecular Events of DNA Damage Response by Flow- and Image-Assisted Cytometry
Darżynkiewicz, Z., Traganos, F., Zhao, H. L., Halicka, H. D., Skommer, J., & Włodkowic, D. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-385493-3.00006-1 · Cited by 32
WRN protects against topo I but not topo II inhibitors by preventing DNA break formation
Christmann, M., Tomicic, M. T., Gestrich, C., Roos, W. P., Bohr, V. A., & Kaina, B. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.08.008 · Cited by 33
Phylogenomics of Unusual Histone H2A Variants in Bdelloid Rotifers
Doninck, K. V., Mandigo, M., Hur, J. H., Wang, P., Guglielmini, J., Milinkovitch, M. C., Lane, W. S., & Meselson, M. S. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000401 · Cited by 32
The nucleosome: orchestrating DNA damage signaling and repair within chromatin
Agarwal, P., & Miller, K. M. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0017 · Cited by 31
Kalfalah, F. M., Mielke, C., Christensen, M. O., Baechler, S. A., Marko, D., & Boege, F. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000509 · Cited by 31
Déry, U., & Masson, J. (2007) · DNA repair · doi:10.1016/j.dnarep.2006.12.009 · Cited by 32
Böğürcü, N., Sevimli-Gür, C., Yelken, B. Ö., Bedіr, E., & Korkmaz, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.078 · Cited by 30
Tanaka, T., Kurose, A., Huang, X., Traganos, F., Dai, W. H., & Darżynkiewicz, Z. (2006) · Cell Proliferation · doi:10.1111/j.1365-2184.2006.00387.x · Cited by 30
Dey, D., Hasan, M. M., Biswas, P., Papadakos, S. P., Rayan, R. Α., Tasnim, S., Bilal, M., Islam, M. J., Arshe, F. A., Arshad, E. M., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.899009 · Cited by 29
γ-H2AX Kinetics as a Novel Approach to High Content Screening for Small Molecule Radiosensitizers
Fu, S., Yang, Y., Das, T. K., Yen, Y., Zhou, B., Zhou, M., Ohlmeyer, M. H. J., Ko, E. C., Cagan, R. L., Rosenstein, B. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038465 · Cited by 29
An unusual DNA binding compound, S23906, induces mitotic catastrophe in cultured human cells
Cahuzac, N., Studény, A., Marshall, K. S., Versteege, I., Wetenhall, K., Pfeiffer, B., Léonce, S., Hickman, J. A., Pierré, A., & Golsteyn, R. M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.014 · Cited by 29
Habraken, Y., Jolois, O., & Piette, J. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206893 · Cited by 29
Cameron, R. S., Liu, C., & Pihkala, J. P. S. (2013) · Cytoskeleton · doi:10.1002/cm.21109 · Cited by 28
Persistent DNA damage signaling and DNA polymerase theta promote broken chromosome segregation
Clay, D. E., Bretscher, H. S., Jezuit, E. A., Bush, K. B., & Fox, D. T. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202106116 · Cited by 28
Huang, T. H., Chen, H.-C., Chou, S.-M., Yang, Y. S. H., Fan, J.-R., & Li, T. (2010) · Cell Research · doi:10.1038/cr.2010.95 · Cited by 28
Self-citationBicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells
Koul, N., Sharma, V., Dixit, D., Ghosh, S., & Sen, E. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-328 · Cited by 28
Truncation mutations abolish chromatin-associated activities of adenomatous polyposis coli
Kouzmenko, A., Takeyama, K., Kawasaki, Y., Akiyama, T., & Kato, S. (2008) · Oncogene · doi:10.1038/onc.2008.127 · Cited by 28
Behrendt, R., & Roers, A. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12147 · Cited by 27
Measurement of H2AX Phosphorylation as a Marker of Ionizing Radiation Induced Cell Damage
Muslimović, A., Johansson, P., & Hammarste, O. (2012) · InTech eBooks · doi:10.5772/33257 · Cited by 27
Shibata, A., Maeda, D., Ogino, H., Tsutsumi, M., Nohmi, T., Nakagama, H., Sügimura, T., Teraoka, H., & Masutani, M. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.02.001 · Cited by 27
A phase II trial of oral gimatecan for recurrent glioblastoma
Hu, J. L., Wen, P. Y., Abrey, L. E., Fadul, C. E., Drappatz, J., Salem, N., Supko, J. G., & Hochberg, F. H. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-1023-0 · Cited by 26
Tang, S., Sheu, G., Wong, R., Huang, C., Weng, M.-W., Lee, L., Hsu, C., & Ko, J. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.11.003 · Cited by 26
The Deubiquitinating Enzyme Doa4p Protects Cells from DNA Topoisomerase I Poisons
Fiorani, P., Reid, R. J. D., Schepis, A., Jacquiau, H. R., Guo, H., Thimmaiah, P., Benedetti, P., & Bjornsti, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312338200 · Cited by 26
RecQ Helicase Somatic Alterations in Cancer
Thakkar, M. K., Lee, J., Meyer, S., & Chang, V. Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.887758 · Cited by 26
Zanchi, C., Zuco, V., Lanzi, C., Supino, R., & Zunino, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2495 · Cited by 25
Genomic analyses identify gene candidates for acquired irinotecan resistance in melanoma cells
Gao, K., LOCKWOOD, W., Li, J., Lam, W., & Li, G. (1992) · International Journal of Oncology · doi:10.3892/ijo_32_6_1343 · Cited by 25
The switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence
Helmbold, H., Galderisi, U., & Bohn, W. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22786 · Cited by 25
Detection of Histone H2AX Phosphorylation on Ser‐139 as an Indicator of DNA Damage
Zhao, H. L., Huang, X., Halicka, H. D., & Darżynkiewicz, Z. (2019) · Current Protocols in Cytometry · doi:10.1002/cpcy.55 · Cited by 25
Mécanismes moléculaires et déterminants de la réponse aux inhibiteurs de topo-isomérases I
Pourquier, P., & Lansiaux, A. (2011) · Bulletin du Cancer · doi:10.1684/bdc.2011.1474 · Cited by 25
Mechanism for local attenuation of DNA replication at double-strand breaks
Sebastian, R., Sun, E. G., Fedkenheuer, M., Fu, H., Jung, S., Thakur, B. L., Redon, C. E., Pegoraro, G., Tran, A. D., Gross, J., et al. (2025) · Nature · doi:10.1038/s41586-024-08557-9 · Cited by 24
Self-citationWang, L., Dai, W. H., & Lu, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.597161 · Cited by 24
Tails of histones in DNA double-strand break repair
Bilsland, E., & Downs, J. A. (2005) · Mutagenesis · doi:10.1093/mutage/gei031 · Cited by 23
Yamauchi, H., Katayama, K., Ueno, M., He, X. J., Mikami, T., Uetsuka, K., Doi, K., & Nakayama, H. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0099-z · Cited by 24
Ovejero, S., Viziteu, E., Dutrieux, L., Devin, J., Lin, Y., Alaterre, E., Jourdan, M., Basbous, J., Requirand, G., Robert, N., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.983181 · Cited by 23
Filho, R. D. L., Yamamoto, G. L., Silva, T. J., Rocha, L. A., Linnenkamp, B. D. W., Castro, M. A. A., Bartholdi, D., Schaller, A., Leeb, T., Kelmann, S. V., et al. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2022-109119 · Cited by 23
Evaluating γH2AX in spermatozoa from male infertility patients
Zhong, H., Lv, F.-T., Deng, X.-L., Hu, Y., Dan-ni, X., Bin, L., Mo, Z., & Lin, F. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.06.004 · Cited by 23
Jensen, L. H., Dejligbjerg, M., Hansen, L. T., Grauslund, M., Jensen, P. B., & Sehested, M. (2004) · BMC Pharmacology · doi:10.1186/1471-2210-4-31 · Cited by 23
Cariveau, M. J., Tang, X., Cui, X.-L., & Xu, B. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.036681 · Cited by 22
Harada, A., Matsuzaki, K., Takeiri, A., & Mishima, M. (2014) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2014.05.010 · Cited by 22
Lin, Z. P., Lee, Y., Lin, F., Belcourt, M. F., Li, P., Cory, J. G., Glazer, P. M., & Sartorelli, A. C. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074708 · Cited by 22
Chang, L., Yu, Y., Liu, C., Cheng, Y., Chou, R., Hsieh, M., Lin, H.-Y., Hung, H., Huang, L.-J., Wu, Y., et al. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2765-0 · Cited by 22
Mei, M. (2010) · Oncology Reports · doi:10.3892/or_00000986 · Cited by 22
Majumdar, A. G., Shree, S., Das, A., Kumar, B. K., Dey, P., Subramanian, M., & Patro, B. S. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115598 · Cited by 21
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL)
Mutonga, M., Tamura, K., Malnassy, G., Fulton, N. C., Albuquerque, A. D. S., Hamamoto, R., Stock, W., Nakamura, Y., & Alachkar, H. (2015) · Translational Oncology · doi:10.1016/j.tranon.2015.07.003 · Cited by 21
DNA damage response (DDR) via NKX3.1 expression in prostate cells
Tepedelen, B. E., Karamil, S., Gonen‐Korkmaz, C., & Korkmaz, K. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.01.001 · Cited by 21
Vasalou, C., Proia, T. A., Kazlauskas, L., Przybyła, A., Sung, M. S., Mamidi, S., Maratea, K., Griffin, M., Sargeant, R., Urosevic, J., et al. (2024) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13133 · Cited by 20
Artemis‐dependent DNA double‐strand break formation at stalled replication forks
Unno, J., Takagi, M., Piao, J., Sugimoto, M., Honda, F., Maeda, D., Masutani, M., Kiyono, T., Watanabe, F., Morio, T., et al. (2013) · Cancer Science · doi:10.1111/cas.12144 · Cited by 20
Guo, L., Liu, X., Jiang, Y., Nishikawa, K., & Plunkett, W. K. (2011) · Molecular Pharmacology · doi:10.1124/mol.109.057125 · Cited by 20
Bianchi, M., Bellini, A., Cervelli, M., Degan, P., Marcocci, L., Martini, F., Scatteia, M., Mariottini, P., & Amendola, R. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.01.014 · Cited by 20
Metadata
- Authors
- Furuta, T., Takemura, H., Liao, Z.-Y., Aune, G. J., Redon, C., Sedelnikova, O. A., Pilch, D. R., Rogakou, E. P., Celeste, A., Chen, H. T., Nussenzweig, A., Aladjem, M. I., Bonner, W. M., & Pommier, Y.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Pommier, Yves
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 278
- Issue
- 22
- Pages
- 20303-20312
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2119186872
- Cited by
- 449
- References
- 72
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 5 · 2023: 19 · 2022: 9 · 2021: 17 · 2020: 11 · 2019: 16 · 2018: 9 · 2017: 6 · 2016: 10 · 2015: 23 · 2014: 19 · 2013: 17 · 2012: 24
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6354 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Keywords
- H2AX phosphorylation, γH2AX foci, DNA double-strand breaks, topoisomerase I cleavage complexes, camptothecin, MRE11, RAD50, NBS1, ATR kinase, DNA-dependent protein kinase, DNA repair, DNA damage checkpoint, wortmannin, 7-hydroxystaurosporine
- MeSH terms
- MRE11 Homologue Protein, Animals, Camptothecin, DNA Damage, DNA Replication, DNA Topoisomerases, Type I, DNA-Binding Proteins, Enzyme Inhibitors, Histones, Humans, Hydrolysis, Nuclear Proteins, Phosphorylation, Tumor Cells, Cultured, Blotting, Western, Mice, Knockout, Microscopy, Confocal, Cell Cycle Proteins, Saccharomyces cerevisiae Proteins, DNA Repair Enzymes, Mice, Topoisomerase I Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.